Live Breaking News & Updates on மிட்செல் க்ரோனன்பெர்க்

Stay updated with breaking news from மிட்செல் க்ரோனன்பெர்க். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Collaboration Explores Therapies for Autoimmune Diseases

Collaboration Explores Therapies for Autoimmune Diseases
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Mitchell Kronenberg , Michaelk Handley , Jolla Institute For Immunology , Jolla Institute , Advanced Immunomodulating Multi Receptor System , மிட்செல் க்ரோனன்பெர்க் , ஜொல்லா நிறுவனம் க்கு நோயெதிர்ப்பு , ஜொல்லா நிறுவனம் ,

Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board


Appia Bio Launches With $52 Million Series A Financing and Establishes Scientific Advisory Board
Proceeds will be used to progress stem cell derived CAR-engineered invariant natural killer T cells (CAR-iNKT) to the clinic in hematological and solid tumor indications
News provided by
Share this article
Share this article
LOS ANGELES, May 11, 2021 /PRNewswire/ Appia Bio, Inc., an early stage biotechnology company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs) for cancer patients, today announced its launch from stealth backed by $52 million Series A financing led by 8VC. Other investors included Two Sigma Ventures, among others, and participation from seed investors Sherpa Healthcare Partners and Freeflow Ventures. ....

University Of Southern California , United States , Los Angeles , Lili Yang , Edmund Kim , Lyell Immunopharma , Mitchell Kronenberg , David Moskowitz , Jeff Wiezorek , Margo Roberts , Antoni Ribas , Appia Bio , David Baltimore , Francisco Gimenez , University Of California , Jonsson Comprehensive Cancer Center , California Institute Of Technology Caltech , Prnewswire Appia Bio Inc , Tumor Immunology Program , Jolla Institute For Immunology , Column Group , Two Sigma Ventures , Sherpa Healthcare Partners , California Institute , Scientific Advisory Board , Kite Pharma ,

Renowned virus hunter Erica Ollmann Saphire to lead La Jolla Institute


Print
Erica Ollmann Saphire, a biologist known internationally for her efforts to fight such deadly viruses as COVID-19 and Ebola, has been named president and chief executive officer of the La Jolla Institute, one of the country’s foremost private biomedical research centers.
Saphire, 49, will succeed Mitchell Kronenberg, who has led LJI for nearly 20 years. He will remain as chief scientific officer.
She will continue to run her lab, which serves as a global clearinghouse in the search for antibodies that might be effective against COVID-19, which has killed 2.65 million people.
Her appointment means that LJI, which is small, has managed to fend off recruiters from other institutions. In the process, LJI will likely become the third local, high-ranking biomedical institute whose president is a woman. Her appointment takes effect on Sept. 1. ....

Sierra Leone , Erica Ollmann Saphire , David Brenner , Erica Ollmann Saphiregroped , Mitchell Kronenberg , Jolla Scripps Research , National Institutes Of Health , J Craig Venter Institute , Melinda Gates Foundation , Jolla Institute , Jolla Institute For Allergy , Sanford Burnham Prebys Medical Discovery Institute , Venter Institute , Sanford Burnham Prebys Medical Discovery , Scripps Research , National Institutes , Melinda Gates , சியரா லியோன் , டேவிட் ப்ரென்னர் , மிட்செல் க்ரோனன்பெர்க் , ஜொல்லா ஸ்கிரிப்ட்கள் ஆராய்ச்சி , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , ஜு கிரேக் வென்டர் நிறுவனம் , மெலிண்டா வாயில்கள் அடித்தளம் , ஜொல்லா நிறுவனம் , ஜொல்லா நிறுவனம் க்கு ஒவ்வாமை ,